ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Osteoarthritis"

  • Abstract Number: 2164 • 2015 ACR/ARHP Annual Meeting

    Burden of Symptomatic Knee Osteoarthritis in the United States: Impact of Race/Ethnicity, Age and Sex

    Bhushan Deshpande1, Jeffrey N. Katz2, Daniel H. Solomon2, Edward H. Yelin3 and Elena Losina2, 1Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 3University of California, San Francisco, San Francisco, CA

    Background/Purpose : Growing evidence suggests that the prevalence and incidence of knee OA is rising, partially due to increasing life expectancy and the growing obesity…
  • Abstract Number: 322 • 2015 ACR/ARHP Annual Meeting

    Reduction of Treatment Needed for Knee Osteoarthritis after Bariatric Surgery

    Evan Wilder1, Janice Lin1, Fernando Bomfim1, Thayer Mukherjee1, Lucy O'Shaughnessy1, Lauren Browne1, Myriam Weill1, Kevin Gernavage1, Farah Taufiq1, Renata La Rocca Vieira2, Christine Ren-Fielding3, Manish Parikh4, Steven B. Abramson5 and Jonathan Samuels6, 1NYU Langone Medical Center, New York, NY, 2Department of Radiology, NYU Langone Medical Center, New York, NY, 3Department of Surgery, New York University School of Medicine, New York, NY, 4Department of Surgery, NYU Langone Medical Center, New York, NY, 5Dept of Rheumatology/Medicine, Hosp for Joint Diseases/NYU, New York, NY, 6Rheumatology, NYU - Hospital for Joint Diseases, New York, NY

    Background/Purpose:  Medical treatment for knee osteoarthritis (KOA) can be limited and risk morbidity. Weight loss reduces the arthritis burden and may preclude aggressive treatment. Bariatric…
  • Abstract Number: 2248 • 2015 ACR/ARHP Annual Meeting

    Knee Pain Burden Is Associated with Decreased Motor Performance: Data from the Osteoarthritis Initiative

    Javad Razjouyan1, Bijan Najafi2, Erin Ashbeck3, Dorothy D. Dunlop4, Julia (Jungwha) Lee5, Lynn Hamilton3 and C. Kent Kwoh6, 1Consortium on Advanced Motion Performance (iCAMP), Department of Surgery, University of Arizona, Tucson, AZ, 2Department of Surgery and Department of Biomedical Engineering, University of Arizona, Tucson, AZ, 3Arthritis Center, University of Arizona, Tucson, AZ, 4Institute for Healthcare Studies, Northwestern University Feinberg School of Medicine, Chicago, IL, 5Department of Preventive Medicine, Biostatistics Collaboration Center, Northwestern University Feinberg School of Medicine, Chicago, IL, 6Rheumatology, University of Arizona, Tucson, AZ

    Background/Purpose: Knee pain is the presenting symptom in knee osteoarthritis (OA), but the impact of knee pain burden in OA has been understudied. We examined…
  • Abstract Number: 336 • 2015 ACR/ARHP Annual Meeting

    Lack of Uniform Diagnostic Criteria for Erosive OA: A Systematic Review

    Supraja Yeturi1, Payal Patel2, Gazeley David2 and Ann K. Rosenthal3, 1Rheuamtology, Medical college of Wisconsin, Milwaukee, WI, 2Medical College of Wisconsin, Milwaukee, WI, 3Div of Rheumatology, Medical College of WI, Milwaukee, WI

    Background/Purpose: Erosive osteoarthritis (EOA) is a potentially important subtype of osteoarthritis initially described in the 1960s.  Since that time, EOA has been the focus of…
  • Abstract Number: 2325 • 2015 ACR/ARHP Annual Meeting

    Quantitative Clues to Recognize and Document Comorbid Fibromyalgia in Routine Care of Patients with Other Rheumatic Diagnoses on a 10 Cm Distress Visual Analog Scale Found on 1-Page Physician Rheumetric Checklist

    Kathryn A. Gibson1, Katherine J. Bryant2 and Theodore Pincus3, 1Liverpool Hospital, Liverpool, Australia, 2University of New South Wales, Sydney, Australia, 3Rheumatology, Rush University Medical Center, Chicago, IL

    Background/Purpose: A physician global estimate (DOCGL) is commonly used to assess patients with rheumatic diseases. Fibromyalgia (FM) has been reported as a comorbidity in 10-35%…
  • Abstract Number: 337 • 2015 ACR/ARHP Annual Meeting

    Construct Validity of the Doyle Index in the Outcome Domain of Joint Activity in Hand Osteoarthritis Patients

    W. Damman1, R. Liu1, M.C. Kortekaas1,2, F.R. Rosendaal3, D. van der Heijde4 and M. Kloppenburg1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Department of Rheumatology, Flevoziekenhuis, Almere-Stad, Netherlands, 3Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands, 4Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: The Outcome Measures in Rheumatology (OMERACT) working group on hand osteoarthritis (OA) has endorsed a preliminary set of core domains for outcome measures in…
  • Abstract Number: 2385 • 2015 ACR/ARHP Annual Meeting

    Arthritis Management in Primary Care and Adherence to National Guidelines – a Swedish Survey Based on the Canadian Physiotherapists Arthritis Care Questionnaire

    Siv Folkhammar Andersson1, Stefan Bergman2,3,4 and Ann Bremander3,4,5, 1Unit of Rehabilitation, Kalmar County Council, Samrehab, Oskarshamn, Sweden, Oskarshamn, Sweden, 2Primary Health Care Unit, Department of Public Health and Community Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, 3Department of Clinical Sciences, Lund, Section of Rheumatology, Lund University, Lund, Sweden, 4FoU Spenshult, Halmstad, Sweden, 5School of Business, Engineering and Science, Halmstad University, Halmstad, Sweden

    Background/Purpose: For patients with osteoarthritis (OA) physical therapy is recommended first line treatment and performed in primary care while patients with rheumatoid arthritis (RA) may…
  • Abstract Number: 1969 • 2014 ACR/ARHP Annual Meeting

    Neurotrophin Receptor p75 (CD271) Defines a Distinct Synovial Fibroblast Subset in Rheumatoid and Osteoarthritic Synovial Tissues with Enhanced Proinflammatory Potential

    Manuel J. Del Rey1, Regina Faré1, Gabriel Criado2, Alicia Usategui1, Vanessa Miranda1, Juan D. Cañete3 and Jose L. Pablos1, 1Servicio de Reumatología, Instituto de Investigación Hospital 12 de Octubre (I+12), Madrid, Spain, 2Grupo de Enfermedades Inflamatorias y Autoinmunes, Instituto de Investigación Hospital 12 de Octubre (I+12), Madrid, Spain, 3Arthritis Unit. Rheumatology Department, Hospital Clínic of Barcelona, Barcelona, Spain

    Background/Purpose Synovial mesenchynmal or stromal cells constitute a heterogeneous cell population difficult to characterize ex vivo due to a paucity of cell markers and are…
  • Abstract Number: 207 • 2014 ACR/ARHP Annual Meeting

    Changes in Knee Compartment Distriubtion of Cartilage Loss and Bone Marrow Lesions over 7 Years: The MOST Study

    Joshua Stefanik1, Ali Guermazi2, Jingbo Niu3, Frank Roemer4, C.E. Lewis5, Neil A. Segal6, Michael Nevitt7 and David T. Felson8, 1Clinical Epidemiology, Boston University, Boston, MA, 2Radiology, Boston University School of Medicine, Boston, MA, 3Clinical Epidemiology Research and Training Unit, Boston University, Boston, MA, 4Klinikum Augsburg, Augsburg, Germany, 5University of Alabama at Birmingham, Birmingham City, AL, 6Orthopaedics and Rehabilitation, University of Iowa, Iowa City, IA, 7Epidemiology and Biostatistics, UCSF, San Francisco, CA, 8Clinical Epidemiology Research & Training Unit, Boston University School of Medicine, Boston, MA

    Background/Purpose: Knee osteoarthritis (OA) occurs in both the patellofemoral joint (PFJ) and tibiofemoral joint (TFJ). Little is known about the natural history of OA and…
  • Abstract Number: 1820 • 2014 ACR/ARHP Annual Meeting

    Discordance of Hip Pain with Radiographic Hip Osteoarthritis: The Osteoarthritis Initiative

    Chan Kim1, Michael C. Nevitt2, Pia M. Jungmann3, Irina Tolstykh4, Nancy E. Lane5, Thomas M. Link6 and David T. Felson7, 1Rheumatology, Boston University, Boston, MA, 2Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA, 3Radiology, Technische Universitaet Muenchen, Munich, Germany, 4Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, 5Internal Medicine, Center for Musculoskeletal Health, UC Davis School of Medicine, Sacramento, CA, 6Musculoskeletal Quantitative Imaging Research Group, Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, 7Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, University of Manchester, Manchester, United Kingdom

    Background/Purpose It is assumed that persons with hip pain from osteoarthritis (OA) are likely to have radiographic OA, making it possible to readily diagnose disease,…
  • Abstract Number: 200 • 2014 ACR/ARHP Annual Meeting

    Leg Length Inequality and Hip Osteoarthritis

    Chan Kim1, Jingbo Niu2, Mary Clancy3, Ali Guermazi4, Michael C. Nevitt5, Neil A. Segal6, William F. Harvey7, Cora E Lewis8 and David T. Felson9, 1Rheumatology, Boston University, Boston, MA, 2Clinical Epidemiology Research and Training Unit, Boston University, Boston, MA, 3Clinical Epidemiology, Boston University Sch Med, Boston, MA, 4Radiology, Boston University School of Medicine, Boston, MA, 5Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA, 6Orthopaedics and Rehabilitation, University of Iowa, Iowa City, IA, 7Rheumatology, Tufts Medical Center, Boston, MA, 8Division of Preventive Medicine, University of Alabama Birmingham School of Medicine, Birmingham, AL, 9Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, University of Manchester, Manchester, United Kingdom

    Background/Purpose Leg length inequality (LLI), a side-to-side difference in lower limb lengths, is common.  In the Multicenter Osteoarthritis Study (MOST), in persons with LLI, the…
  • Abstract Number: 1800 • 2014 ACR/ARHP Annual Meeting

    Objectively Measured Sedentary Behavior Is a Distinct Risk Factor from Low Moderate-to-Vigorous Activity in Predicting Subsequent Frailty: Evidence from Osteoarthritis Initiative

    Jing Song1, Lee A. Lindquist1, Rowland W. Chang1, Pamela A. Semanik2, Linda S. Ehrlich-Jones3, Jungwha Lee4, Min-Woong Sohn1 and Dorothy D. Dunlop1, 1Northwestern University Feinberg School of Medicine, Chicago, IL, 2Rush University Medical Center, Chicago, IL, 3Rehabilitation Institute of Chicago, Chicago, IL, 4Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose: Physical frailty represents a state of high vulnerability for adverse health outcomes including disability and mortality. Physical activity interventions to improve health have largely…
  • Abstract Number: 197 • 2014 ACR/ARHP Annual Meeting

    Differences in Total Hip Replacement Outcomes Based on Age

    Leslie Harrold1, David Ayers2, Wenjun Li2, Courtland Lewis3, Philip Noble4, Regis O'Keefe5, Jeroan Allison6 and Patricia D. Franklin2, 1Department of Orthopedics and Medicine, University of Massachusetts Medical School, Worcester, MA, 2Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, 3Hartford Hospital, Hartford, CT, 4Baylor College of Medicine, Houston, TX, 5University of Rochester Medical Center, Rochester, NY, 6Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA

    Background/Purpose:  The fastest growing segment of patients who undergo total hip replacement (THR) are younger than 130 surgeons across 22 states in the US.  The…
  • Abstract Number: 1420 • 2014 ACR/ARHP Annual Meeting

    Non-Use of Glucocorticoid and Osteoarthritis Absence As Predictors of Clinical Remission in AR

    Salvador Loredo-Alanís1, David Vega-Morales2, Mario Garza-Elizondo1, Mario Garcia-Pompermayer3, Roberto Negrete-López1, Daniel Treviño-Montes1 and Diana Flores-Alvarado2, 1Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico, 2Rheumatology, Hospital Universitario UANL, Monterrey, Mexico, 3Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterey, Mexico

    Background/Purpose The clinical evaluation of Rheumatoid arthritis (RA) is accomplished with compound indexes allowing better clinical decision. Clinical remission nowadays is an attainable target in…
  • Abstract Number: 187 • 2014 ACR/ARHP Annual Meeting

    Revision Arthroplasty in Rheumatoid and Osteoarthritis: Does Methotrexate Decrease Radiographic Lucency in RA Patients?

    Mike Wei1, Douglas N. Mintz2, Lisa A. Mandl3, Arielle Fein4, Jayme C. Burket5, Yuo-Yu Lee4, Wei-Ti Huang6, Vivian P. Bykerk4, Mark P. Figgie7, Edward F. DiCarlo8, Bruce N. Cronstein9 and Susan M. Goodman3, 1Weill Cornell Medical College, New York, NY, 2Radiology, Hospital for Special Surgery, New York, NY, 3Rheumatology, Hospital for Special Surgery, New York, NY, 4Hospital for Special Surgery, New York, NY, 5Healthcare Research Institute, Hospital for Special Surgery, New York, NY, 6Biostatistics, Hospital for Special Surgery, New York, NY, 7Orthopedics, Hospital for Special Surgery, New York, NY, 8Pathology, Hospital for Special Surgery, New York, NY, 9NYU School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose Rheumatoid arthritis (RA) patients have excellent total hip arthroplasty (THA) survival, and methotrexate (MTX), an anti-inflammatory disease modifying drug which may affect bone reabsorption,…
  • « Previous Page
  • 1
  • …
  • 53
  • 54
  • 55
  • 56
  • 57
  • …
  • 63
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology